skip to main content

    Updated Visitor Guidelines

 

MENU

 

Cancer

U-M Rogel Cancer Center Urges Priority Access to the COVID-19 Vaccines for Cancer Patients and Survivors

130 organizations and cancer centers underscore the importance of prioritizing patients with active cancer and survivors of cancer for lifesaving COVID-19 vaccines.

Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer

Novel finding suggests a possible target for improving response to immune-based cancer treatments

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy

Researchers develop enhanced communication framework for cancer clinics

Authors account for both verbal and nonverbal communication among doctors, medical staff and cancer patients

Research finds possible therapies to target oncogenic transcription factors in multiple cancer types

Investigators have furthered the idea that inhibiting the SWI/SNF epigenetic complex can therapeutically target oncogenic transcription factors

Researchers find common immune system mechanism between pregnancy, cancer

By understanding how immune response is suppressed in pregnancy, researchers pinpoint key mechanism that stops immune system from blocking cancer

ASCO 2024: Rogel Recap of the 2024 ASCO Annual Meeting

A brief recap of Rogel Cancer Center researcher presentations at ASCO 2024 in Chicago.

Researchers Find Cellular Evidence Behind Lasting Immune Response in Some Cancer Survivors

Immunotherapy researchers have discovered how a subset of T cells known as memory T cells are generated in melanoma survivors with vitiligo and able to function for years after a tumor is gone.

Pages